Search global stocks & ETFs...Ctrl K
Learn Mode
ZBH
Stock Profile
08-05
Recommended Metric
Score Card
Explore Scores Tab
3.55
Good
Valuation Score
Key Score
3.00
Average
Management
1.00
Very Bad
Growth
3.00
Average
Profitability
3.00
Average
Fin. Health
4.00
Good
Dividends
3.00
Average
Analyst
2.00
Bad
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$87.16
Baseline
High
$135.57
▲
55.54%
Avg
$100.67
▲
15.51%
Low
$83.83
▼
-3.82%
Analyst Ratings based on 34 Analysts
Strong Buy
412%
Buy
824%
Hold
2059%
Sell
206%
Strong Sell
000%
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana and currently employs 17,000 full-time employees. The company went IPO on 2001-07-25. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. The company also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.Read More
Stock News
View All Updates
Is Zimmer Biomet Stock Underperforming the S&P 500?
2dYahoo
Is Solventum Corporation (SOLV) A Good Stock To Buy Now?
6dYahoo
Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates
1wYahoo
Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?
1wYahoo
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?
1wYahoo
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
1wYahoo
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
1wSeekingAlpha
Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?
1wYahoo
Here's How Financial Strength Remains a Key Advantage for GMED
1wYahoo
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
2wYahoo
Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
2wYahoo
2 Profitable Stocks to Consider Right Now and 1 We Question
2wYahoo
GE HealthCare (GEHC) Up 3.3% Since Last Earnings Report: Can It Continue?
2wYahoo
Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $93
2wBenzinga
Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?
2wYahoo
3 Healthcare Stocks That Fall Short
2wYahoo
THINK Surgical Announces the TMINI® Miniature Robotic System 5,000th Procedure Milestone
3wYahoo
3 Reasons to Sell ZBH and 1 Stock to Buy Instead
3wYahoo
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?
3wYahoo
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
3wYahoo
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
4wYahoo
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?
4wYahoo
[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
4wYahoo
Why Zimmer Biomet (ZBH) Stock Is Up Today
4wYahoo
What Are Wall Street Analysts' Target Price for Zimmer Biomet Stock?
4wYahoo
Zimmer Biomet (ZBH) Valuation Check After Announcing Expanded US$1b Share Repurchase Plan
4wYahoo
Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?
4wYahoo
Jim Cramer Discusses the Performance of Danaher and Its Peers
4wYahoo
3 Out-of-Favor Stocks We Approach with Caution
5wYahoo
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
5wSeekingAlpha
Transcript : Zimmer Biomet Holdings, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08
5wFinnhub
These S&P500 stocks are moving in today's session
5wChartMill
Which S&P500 stocks are moving on Tuesday?
5wChartMill
Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End
5wYahoo
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
5wBenzinga
Zimmer Biomet Increases Its 2026 Share Buyback Target By $250M To $1B
5wBenzinga
Jim Cramer on the current market: Hated companies are over-hated, and the loved ones are over-loved
5wCNBC
Jim Cramer says today’s market is punishing stocks harder than 1999
5wCNBC
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
5wSeekingAlpha
Investors Can Find Comfort In Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Quality
5wYahoo
Moat Strategies Join Tech-Led April Rebound
5wSeekingAlpha
[Latest] Global Surgical Case Carts Market Size/Share Worth USD 686.99 Million by 2035 at a 4.04% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
5wYahoo
Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference
6wYahoo
Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Term
6wYahoo
A Look At Zimmer Biomet (ZBH) Valuation After CFO Exit And Solid Quarterly Results
6wYahoo
Stryker's Fundamentals 'Solidly Intact' Despite Cyber Disruption, RBC Says
7wYahoo
Zimmer Biomet Supported by Sales Force Improvements, 2026 Upside Potential, RBC Says
7wYahoo
JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $95
7wBenzinga
Teva Pharmaceutical (TEVA): David Einhorn Likes This Pharma Stock
7wYahoo
Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $95
7wBenzinga